股票行情快报：天臣医疗（688013）2月5日主力资金净卖出564.80万元

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tianchen Medical (688013), indicating a slight decline in stock price and notable financial growth in revenue and profit [1][2]. Group 2 - As of February 5, 2026, Tianchen Medical's stock closed at 41.93 yuan, down 1.55%, with a turnover rate of 1.18% and a trading volume of 9,582 lots, amounting to a transaction value of 40.27 million yuan [1]. - The net outflow of main funds was 564.8 thousand yuan, accounting for 14.03% of the total transaction value, while retail investors saw a net inflow of 500.42 thousand yuan, representing 12.43% of the total [1]. - For the first three quarters of 2025, Tianchen Medical reported a main revenue of 244 million yuan, a year-on-year increase of 20.66%, and a net profit attributable to shareholders of 71.95 million yuan, up 68.29% year-on-year [2]. - The third quarter of 2025 showed a single-quarter main revenue of 87.66 million yuan, a 26.4% increase year-on-year, and a net profit of 23.73 million yuan, reflecting a 70.74% year-on-year growth [2]. - The company maintains a debt ratio of 11.3% and a gross profit margin of 63.22% [2].